Tramadol in the treatment of neuropathic cancer pain: A double-blind, placebo-controlled study

Clinical Drug Investigation

Volumn 27, Issue 1, 2007, Pages 75-83

  Arbaiza, Daniel ^a   Vidal, Oscar ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRAMADOL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PAIN; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; LEUKEMIA; LUNG CANCER; LYMPHOMA; MALE; NAUSEA; NEUROPATHIC PAIN; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP PATTERN; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VOMITING;

EID: 33846038812     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200727010-00007     Document Type: Article

References (38)

1. Mantyh PW. Cancer pain: causes, consequences and therapeutic opportunities. Chapter 69. In: McMahon SB, Koltzenburg M, editors. Wall and Melzack's textbook of pain. 5th edition. China: Elsevier Churchill Livingstone, 2006: 1087-97
2. Stute P, Soukup J, Menzel M. Analysis and treatment of different types of neuropathic cancer pain. J Pain Symptom Manage 2003; 26: 1123-31
3. Sindrup SH, Jensen TS. Efficacy of pharmacological treatment of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1991; 63: 389-400
4. Raffa RB, Friderichss E, Reimann W, et al. Opioid and non-opioid components independently contribute to the mechanisms of action of tramadol, an atypical opioid analgesic. J Pharmacol Exp Ther 1992; 260: 275-85
5. Babul N, Noveck R, Chipman H, et al. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symtom Manage 2004; 28: 59-71
6. Grond S, Radbruch L, Meuser T, et al. High-dose tramadol in comparison to low-dose morphine for cancer pain relief. J Pain Symptom Manage 1999 Sep; 18 (3): 174-9
7. Leppert W, Luczak J. The role of tramadol in cancer pain treatment: a review. Support Care Cancer 2005 Jan; 13 (1): 5-17
8. Mercante S, Arcuri E, Fusco F, et al. Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain. Support Care Cancer 2005 Sep; 13 (9): 702-7
9. Petzke F, Radbruch L, Sabotowski R, et al. Slow-release tramadol for treatment of chronic malignant pain an open multicenter trial. Support Care Cancer 2001 Jan; 9 (1): 48-54
10. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998; 50: 1842-6
11. Sindrup SH, Andersen G, Madsen C, et al. Tramadol relieves p ain and allodynia in polyneuropathy: a randomized, double-blind, controlled trial. Pain 1999; 83: 85-90
12. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind placebo-controlled trial. Pain 2003; 104: 323-31
13. Harati Y, Gooch C, Swenson M, et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications 2000; 14: 65-70
14. Duhmke R, Cornblath D, Hollingshead J. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2004; (2): CD003726
15. Hollingshead J, Duhmke RM, Cornblath DR. Tramadol for neuropathic pain. The Cochrane Library 2006, (3): CD003726
16. Piantadosi S. Clinical trials: a methodological perspective. New York: Wiley-Interscience Publication, John Wiley & Sons, Inc. 1997: 166
17. Melzack R, Katz J. Pain assessment in adult patients. Chapter 18. In: McMahon SB, Koltzenburg M, editors. Wall and Melzack's textbook of pain. 5th Edition. China: Elsevier Churchill Livingstone 2006: 291-304
18. Karnofsky DA, Abelman WH, Craver LF, et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948; 1: 634-56
19. Zung, W. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70
20. Conde V, Esteban Chamorro T. Revisión crítica de dos adaptaciones castellanas de la "A self-rating depression scale" de Zung. (Critical revision of two Spanish adaptations of the "A self-rating depression scale" of Zung). Arch Neurobiol (Madrid) 1973; 36: 375-92
21. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988; 8 (1): 77-100
22. Kalso E, Tasmuth T, Neuvonen PJ. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer pain. Pain 1995; 64: 293-302
23. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999; 83 (3): 389-400
24. Fassoulaki A, Patris K, Sarantopoulos C, et al. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg 2002; 95: 985-91
25. Cherny NI, Thaler HT, Friedlander-Klar H, et al. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled single-dose studies. Neurology 1944; 44: 857-61
26. Schug SA, Gandham N. Opioids: clinical use. Chapter 28. In: McMahon SB, Koltzenburg M, editors. Wall and Melzack's textbook of pain. 5th Edition. China: Elsevier Churchill Livingstone, 2006: 443-57
27. McQuay HJ, Jadad AR, Carroll D, et al. Opioid sensitivity of chronic pain: a patient-controlled analgesia method. Anaesthesia 1992; 47: 757-67
28. Kelly LS, Nina HH. Tramadol: a new centrally acting analgesic. Am J Health Syst Pharm 1997; 54: 643-52
29. Miranda HF, Pinardi G. Antinociception, tolerance, and physical dependence comparison between morphine and tramadol. Pharmacol Biochem Behav 1998; 61: 357-60
30. Cicero TJ, Adams EH, Geller A, et al. A postmarketing surveillance program to monitor Ultram® (tramadol hydrochloride) abuse in the Unites States. Drug Alcohol Depend 1999; 57 (1): 7-22
31. Gobel H, Stadler T. Treatment of post-herpes zoster pain with tramadol: results of an open pilot study versus clomipramine with or without levomepromazine. Drugs 1997; 53: 34-9
32. Wilder-Smith CH, Hill LT, Laurent S. Postamputation pain and sensory changes in treatment-naive patients: characteristics and responses to treatment with tramadol, amitriptyline, and placebo. Anesthesiology 2005; 103: 619-28
33. Cook R, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 310: 452-4
34. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005 Dec 5; 118 (3): 289-305
35. Duggan A. Pharmacoeconomic aspects of the use of tramadol hydrochloride. Rev Contemp Pharmacother 1995; 6: 541-5
36. Ruoff GE. Slowing the initial titration rate of tramadol improves tolerability. Pharmacotherapy 1999; 19: 88-93
37. Tagarro I, Herrera J, Barutell C, et al. Effect of a simple dose-escalation schedule on tramadol tolerability: assessment in the clinical setting. Clin Drug Invest 2005; 25: 23-31
38. Dworkin RH, Bakconja M, Rowbotham MC, et al. Advances in neuropathic pain. Arch Neurol 2003; 60: 1524-34